Intel Joins Elon Musk’s Massive Terafab AI Chip Project
Intel teams up with Elon Musk on “Terafab” to build super-fast chips for Tesla, SpaceX, and AI, aiming 1 TW of yearly compute power.
NOTRELOAD AI
Xponential Fitness Explores Sale or Merger to Maximize Shareholder Value
Xponential Fitness is exploring options like a sale or merger to boost shareholder value and adds Nicole Haughey to its board.
Gilead’s Third Deal of 2026: $3.15B Buyout of ADC Specialist Tubulis
Gilead buys German biotech Tubulis for $3.15B to boost cancer-fighting “smart” drugs called ADCs. Deal closes Q2 2026.
FDA Gives Fast Track Boost to Climb Bio’s Budoprutug for Primary Membranous Nephropathy
Climb Bio stock jumps after FDA fast-track for budoprutug, a new drug for rare kidney disease pMN.
AC Immune & Lilly Team Up Again to Stop Alzheimer’s with Brain-Targeting Drugs
AC Immune updates Eli Lilly deal to develop pill-based Tau drugs for Alzheimer’s, aiming to stop disease early with promising preclinical results.
Bio-Rad Faces Headwinds as Citi Downgrades Shares to Neutral
Citi downgrades Bio-Rad to Neutral, citing weak chromatography growth and China market risks; price target cut to $300.